Full Text
Cost Comparison of Wet Age-Related Macular Degeneration Treatment with Aflibercept or Ranibizumab

Abstract

Authors

K Gerasimova EV Derkach

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×